Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 69097-942

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 69097-942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lurasidone_120mg (Lurasidone HCl 120 mg)

Lurasidone Hydrochloride 120 mg film-coated tablets label from Cipla USA, Inc. The label states prescription only, contains 30 tablets, and instructs pharmacists to dispense the medication guide separately. It includes storage instructions and manufacturer information for InvaGen Pharmaceuticals, a Cipla subsidiary.*

FDA Label Image

Lurasidone_20mg (Lurasidone HCl 20 mg)

Label for Lurasidone Hydrochloride 20 mg film-coated tablets from Cipla USA, Inc. The label states the product is prescription-only, includes NDC 69097-942-02, and contains 30 tablets. It includes storage instructions, dosing reference to the package insert, and manufacturer information for InvaGen Pharmaceuticals, a Cipla subsidiary.*

FDA Label Image

Lurasidone_40mg (Lurasidone HCl 40 mg)

Lurasidone Hydrochloride 40 mg film-coated tablets label for oral use, containing 30 tablets. The label includes dosage and storage instructions, manufacturer details (ImvGen Pharmaceuticals and Cipla USA, Inc.), and a barcode. The label also notes 'Rx Only' and directs pharmacists to dispense the Medication Guide separately.*

FDA Label Image

Lurasidone_60mg (Lurasidone HCl 60 mg)

Lurasidone Hydrochloride 60 mg film-coated tablets label from Cipla USA, Inc. The label includes the drug name, dosage strength of 60 mg, and instructions for pharmacists to dispense the medication guide separately. Also present is storage information, manufacturer details (InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary), and packaging size of 30 tablets. A barcode and reference to controlled room temperature storage are shown.*

FDA Label Image

Lurasidone_80mg (Lurasidone HCl 80 mg)

Label for Lurasidone Hydrochloride 80 mg film-coated tablets by Cipla USA, Inc. The label indicates it is a prescription drug with 30 tablets per package. Usage instructions and storage conditions are noted, along with manufacturer details for InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd.*

FDA Label Image

Lurasidone Hydrochloride_fig1 (Lurasidone Fig01)

A clinical pharmacokinetic interaction chart showing fold change and 90% confidence intervals for Cmax and AUC of lurasidone when co-administered with various drugs. The chart compares changes relative to lurasidone alone with strong CYP3A4 inhibitors (Ketoconazole), moderate CYP3A4 inhibitors (Diltiazem), and strong CYP3A4 inducers (Rifampin, Lithium) at specified doses.*

FDA Label Image

Lurasidone Hydrochloride_fig2 (Lurasidone Fig02)

A forest plot illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, and Ctrough) of various interacting drugs relative to their levels when administered alone. The drugs assessed include Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium, indicating their interaction profiles with a referencing vertical line at zero change.*

FDA Label Image

Lurasidone Hydrochloride_fig3 (Lurasidone Fig03)

A pharmacokinetic chart illustrating fold change and 90% confidence intervals for Lurasidone Hydrochloride. The x-axis represents change relative to reference on a scale from 0 to 6. Data categories include renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate, severe), and population subgroups by gender, race, and Asian ethnicity, showing Cmax and AUC parameters with error bars.*

FDA Label Image

Lurasidone_structure (Lurasidone Structure01)

Chemical structure of Lurasidone Hydrochloride, depicting its molecular arrangement including carbon, hydrogen, nitrogen, oxygen, sulfur atoms, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.